Chad P. Bown
Peterson Institute
Washington, DC, United States
Contact Chad
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Chad:
Global Economic Prospects: Spring 2022
Karen Dynan, Chad P. Bown, and Steven Fries will present PIIE's semiannual Global Economic Prospects. → Read More
Russia's war on Ukraine: A sanctions timeline
This page tracks economic sanctions by the United States, European Union, United Kingdom, and other major economies on Russia as well as against Belarus, providing notable details about their execution, context with wartime events, and links to formal government actions and PIIE analysis. → Read More
China bought none of the extra $200 billion of US exports in Trump's trade deal
Two years ago, President Donald Trump signed what he called a "historical trade deal" with China that committed China to purchase $200 billion of additional US exports before December 31, 2021. → Read More
Trump ended WTO dispute settlement. Trade remedies are needed to fix it.
Unhappy with the rulings of the WTO dispute settlement system, which disproportionately targeted US use of trade remedies, the United States ended the entire system in 2019. → Read More
Subsidies are on the rise. Are they a necessary evil?
The number of subsidies is increasing worldwide, even more since the onset of the pandemic. From a domestic point of view, many subsidies provide much needed economic support during hard times, but some are harming the global trading system. Which ones are harmful—and how many are there in fact? → Read More
Don't let CureVac's COVID-19 vaccine supply chain go to waste
In mid-June, CureVac, the heavily subsidized German biotech firm, recorded surprisingly poor results in final-stage clinical trials of its COVID-19 vacci → Read More
How COVID-19 medical supply shortages led to extraordinary trade and industrial policy
Early in the COVID-19 pandemic, a global shortage of hospital gowns, gloves, surgical masks, and respirators caused policymakers around the world to panic. → Read More
Here's how to get billions of COVID-19 vaccine doses to the world
The unprecedented development of several effective COVID-19 vaccines in less than a year is an historic achievement in the annals of scientific research. → Read More
The US–China trade war and phase one agreement
The Trump administration changed US trade policy toward China in ways that will take years for researchers to sort out. This paper makes four specific contributions to that research agenda. → Read More
Anatomy of a flop: Why Trump's US-China phase one trade deal fell short
The Biden administration plans to review the phase one trade agreement President Donald Trump forged with China in late 2019. Good. → Read More
The negative effects of tariffs on downstream sectors
In a world in which production processes are fragmented across countries, the effects of tariffs propagate along supply chains, with firms in downstream industries suffering from protection upstream. This column studies the effects of US antidumping duties applied against China – its most frequent target – over 1988-2016 on US firms in downstream sectors. It finds that → Read More
Trump's phase one trade deal with China and the US election
President Donald Trump has staked a claim to success in his trade war with China on his phase one trade agreement of January 2020. → Read More
How Trump's export curbs on semiconductors and equipment hurt the US technology sector
President Donald Trump’s much-touted “phase one” trade agreement with China is falling well short of its goal. Under the deal, Trump pledged that China would purchase an additional $200 billion of US exports over 2020 and 2021. → Read More
US-China phase one tracker: China’s purchases of US goods
On February 14, 2020, the Economic and Trade Agreement Between the United States of America and the People’s Republic Of China: Phase One went into effect. China agreed to expand purchases of certain US goods by a combined $200 billion over 2020 and 2021 from 2017 levels. → Read More
China should export more medical gear to battle COVID-19
China has earned much of the blame it has received for alerting the world too slowly to the novel coronavirus outbreak that originated in Wuhan. → Read More
How the G20 can strengthen access to vital medical supplies in the fight against COVID-19
The COVID-19 pandemic has tested the resilience of the global trading system, and the system has catastrophically botched the test. → Read More
COVID-19: Trump’s curbs on exports of medical gear put Americans and others at risk
At a time of frightening shortages of vital medical equipment to fight the COVID-19 pandemic, the Trump administration has taken bold, decisive action—to make the shortages worse. → Read More
Global value chains and trade protection
The decades preceding the Trump era saw a significant decline in trade barriers and a concurrent rise in global value chains. Evidence on the direction of causality between the two is still lacking. Using an exogenously timed WTO requirement for countries to re-evaluate previously imposed tariffs, this column argues that increased activity through global value chains had an → Read More
EU limits on medical gear exports put poor countries and Europeans at risk
Faced with dangerous shortages at a time of health crisis, the European Union (EU) has announced emergency export restrictions on some hospital supplies that its medical workers need to fight the COVID-19 pandemic. → Read More
Trump's trade policy is hampering the US fight against COVID-19
An alarming unintended consequence of President Donald Trump’s misguided trade war with China has suddenly threatened to cripple the US fight against the COVID-19 pandemic. The administration’s tariffs on Chinese medical products may contribute to shortages and higher costs of vital equipment at a time of nationwide health crisis. → Read More